for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Australian Clinical Labs Ltd

ACL.AX

Latest Trade

4.68AUD

Change

-0.01(-0.21%)

Volume

2,461,045

Today's Range

4.57

 - 

5.08

52 Week Range

3.18

 - 

5.08

As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay

Latest Developments

Australian Clinical Labs FY Revenue Rose 29 Percent To A$ 674.4 Million

Aug 26 (Reuters) - Australian Clinical Labs Ltd <ACL.AX>::FY REVENUE ROSE 29 PERCENT TO A$ 674.4 MILLION.FY NET PROFIT AFTER TAX (NPAT) INCREASED 659.1% TO A$88.7M.

Australian Clinical Labs Says Upgraded FY21 Total Revenue Guidance

June 3 (Reuters) - Australian Clinical Labs Ltd <ACL.AX>::REVISED FY21 TOTAL REVENUE GUIDANCE $657.7 - $663.3 MILLION.ANTICIPATED THAT FY21 PRO-FORMA NPAT WILL BE 10% TO 15% HIGHER THAN FY21 FORECAST DISCLOSED IN PROSPECTUS.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up